FIELD: medicine; virology.
SUBSTANCE: disclosed is a reassortant vaccine strain of influenza virus A/17/Michigan/2020/484 (H3N2), deposited in the State Collection of Viruses of the Ivanovskiy Institute of Virology, Federal State Budgetary Institution “Gamaleya Research Institute of Epidemiology and Microbiology” of the Ministry of Health of Russia, under No. 2994. Vaccine strain A/17/Michigan/2020/484 (H3N2) – reassortant is obtained by crossing the epidemic virus A/Michigan/173/2020 (H3N2) (A/Darwin/9/2021 (H3N2)-like) with cold-adapted temperature-sensitive virus A/Leningrad/134/17/57 (H2N2) – an attenuation donor, harmless to humans.
EFFECT: strain A/17/Michigan/2020/484 (H3N2) enables to obtain a live influenza intranasal vaccine for preventing the incidence of influenza in adults and children.
1 cl, 1 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/DARWIN/2021/410 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825673C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/HONG KONG/2019/2573 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783894C1 |
| REASSORTANT VACCINE STRAIN OF INFLUENZA VIRUS A/17/TASMANIA/2020/151 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2023 |
|
RU2825672C1 |
| REASSORTANT STRAIN OF INFLUENZA A/17/DARWIN/2018/154 (H1N1)PDM09 VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825670C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2019/276 (H1N1) PDM09 FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783878C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/GUANGDONG-MAONAN/2019/211 (H1N1)PDM09 FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2793387C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/3610 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2734897C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/SOUTH AUSTRALIA/2019/122 (H3N2) FOR PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783877C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/NEWCASTLE/2018/22 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783887C1 |
| VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
